Ignasi Barba Vert2026-03-16T10:08:12+01:00

Ignasi Barba Vert

Coordinator of the research line of Cancer profiling

Email: ignasi.barba@uvic.cat

ORCID: 0000-0001-9886-3776

Scientific Profile: URECERCA

Ignasi Barba is an Assistant Professor at the University of Vic-Central University of Catalonia (UVic-UCC). Also, as a resercher he is adscribed to the Institute for Research and Innovation in Life and Health Sciences in Central Catalonia (IRIS-CC). He holds a Degree in Biochemistry (UAB, 1993), a Ph.D in Biochemistry (UAB, 1999).

Teaching responsibilities of Ignasi Barba at the UVic-UCC include physiology and biochemistry at Medical School.

As a researcher, Ignasi Barba joined the TLR2Lab in January 2026, previous positions include Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Research (VHIR) and The University of Cambridge. Most of his career has ben devoted to the study of metabolism, mainly through magnetic resonance spectroscopy. Current interest is the study of tumour metabolism, specifically the role of metabolic alterations in the interaction between tumour cells and the microenvironment.

My last happenings:

Exploiting Hormesis for Plasma-treated Hydrogel Therapeutic platforms (HormeTic)

Subprojects: Subproject 1: "Exploiting Hormesis for plasma-treated hydrogel therapeutic platforms for cancer treatment (HormOnc)". Subproject 2: "Exploiting Hormesis for plasma-treated hydrogel therapeutic platforms for Healing of complex cutaneous wounds (HormHeal)". Original Title (English): Exploiting Hormesis for plasma-treated hydrogel therapeutic platforms for Healing of complex cutaneous wounds (HormHeal). Objective: Innovating in the healing of complex wounds. TR2Lab research team members: Albert Espona-Noguera (Principal Investigator). Cristina Canal (PI1 of Subproject 1) & Francesco Tampieri (PI2 of Subproject 1). Members of TR2Lab who participate in this project: Elisabet Sarri, Laia Bosch, Gemma Sangüesa, Francesc Sant Masoliver, Cristina Martin Mancera, David Benito Guasch, Clara Masó [...]

October 20, 2026|

Lactic acid as a marker of therapeutic response

Members: Dr M. Parera (CHV), Dr I. Barba (Medicina UVic) Financial support: APR-IRIS-CC The Project “Lactic acid as a marker of therapeutic response” has received approval from the IRIS-CC ethics committee and will start recruiting patients in earnest. The project is a collaboration between Consorci Hospitalari de Vic (Dr M. Parera) and the faculty of medicine UVic (Dr I.Barba) and will evaluate lactic acid as a potential marker of therapeutic response in non-small cell lung cancer patients. We would like to thank all the patients who selflessly participate in this project. El projecte «L'àcid làctic com a [...]

October 2, 2026|

Predictors of Recurrence and Survival in Endometrial Cancer: A 22-Year Single-Center Cohort Study

Funding:   Industrial Doctorates Plan of the Government of Catalonia (Industrial Doctorate; DI-2024-00104)  Osona Contra el Càncer (OCC)  «Ajuts per a Projectes de Recerca Interns» call of the Fundació d’Estudis Superiors en Ciències de la Salut (FESS; APR-2025-FESS)      Authors: E. Sardo (1,6,7,8,), M. Alejo Sánchez (2,7), M. Parera Roig (1,6,7,8,), C. Cruz Zambrano (6,7,8,), N. Espejo Herrera (2,8), K. Salas León (2), A. Canet Gómez (2), M. Armengou Ríos (2), C. Vila Díaz (2), E. Puigoriol Juvanteny (3), S. Moros Weakner (4), V. Álvarez Torrecillas (4), I. Gallego Anton (8), M.Panadès Tejero (8), M. Zarcero Estevez (5), S. Griñó [...]

October 2, 2026|
Go to Top